Wiltrom Co

Wiltrom Co Div.-Adj. PEG

The Dividend-Adjusted PEG Ratio of Wiltrom Co (6767.TWO) as of Oct 27, 2026 is 185.50. In the previous year, Dividend-Adjusted PEG Ratio was 38.69 — a change of 379.41% (higher).

Div.-Adj. PEG

185.50

YoY

379.41%

Last updated:

Dividend-Adjusted PEG Ratio of Wiltrom Co is 2023 185.50 . Dividend-Adjusted PEG Ratio of Wiltrom Co was 2022 38.69 . It decreases by 379.41% higher compared to the previous year.

The Wiltrom Co Div.-Adj. PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Div.-Adj. PEG
Date
Div.-Adj. PEG
Jan 1, 2016
866.84 TWD
Jan 1, 2019
38.69 TWD
Jan 1, 2023
185.50 TWD
The Wiltrom Co Div.-Adj. PEG history
YEARDiv.-Adj. PEGYoY
185.50+379.41%
38.69-95.54%
866.84—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wiltrom Co Stock analysis

What does Wiltrom Co do? Wiltrom Co., Ltd. generates revenue through the research, production, and distribution of high-end medical devices, including spinal fixators, artificial bones, and interbody fusion cages. The company focuses on Class II and Class III implantable devices, targeting spinal fusion surgery, spinal compression fracture surgery, and bone cement product segments. Its primary markets are Taiwan, Asia, and America, where it sells directly to hospitals and medical institutions. The firm's product portfolio is designed for specialized surgical procedures, with spinal fusion surgery products forming a core segment of its business. The company's revenue streams are derived from the sale of spinal fixators, artificial bones, and interbody fusion cages, which are categorized under spinal fusion surgery, spinal compression fracture surgery, and bone cement product segments. These products are distributed across Taiwan, Asia, and America, with a strong emphasis on the spinal fusion surgery market. Wiltrom's focus on high-end, implantable Class II and Class III medical devices ensures a premium pricing strategy, aligning with the specialized needs of surgical procedures. Wiltrom Co., Ltd. serves healthcare providers in Taiwan, Asia, and America, delivering Class II and Class III medical devices for spinal fusion, spinal compression fracture, and bone cement applications. The company's products are tailored to specific surgical segments, with spinal fusion surgery products representing a significant portion of its sales. Revenue is generated through direct sales to hospitals and medical institutions within its key geographic markets. Wiltrom Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wiltrom Co stock

Dividend-Adjusted PEG Ratio of Wiltrom Co is 185.50 in 2023.

Dividend-Adjusted PEG Ratio of Wiltrom Co changed from 38.69 to 185.50, representing a 379.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Dividend-Adjusted PEG Ratio Wiltrom Co since 2006 – with annual values, charts, and detailed analysis.

The dividend-adjusted PEG ratio factors in dividend yield alongside earnings growth, providing a more complete valuation for income-paying stocks.

To evaluate Dividend-Adjusted PEG Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Dividend-Adjusted PEG Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Dividend-Adjusted PEG Ratio's Wiltrom Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Wiltrom Co

All Key Metrics — Wiltrom Co